Joao Pedro de Magalhaes

Joao Pedro de Magalhaes is a prominent figure in the field of molecular biogerontology, currently serving as the Chair of Molecular Biogerontology at the University of Birmingham since 2022. As the Chief Scientific Officer at YouthBio Therapeutics Inc., Joao is focused on developing rejuvenation gene therapies utilizing Yamanaka factors. Joao also holds advisory roles with various organizations, including the BOLD Longevity Growth Fund and NOVOS, contributing to advancements in longevity biotechnology. In addition, Joao founded Oxford Cryotechnology and Magellan Science Ltd., both of which emphasize innovative approaches to aging and cryopreservation. With a robust educational background including postdoctoral training at Harvard Medical School and a PhD from Université de Namur, Joao continues to influence cutting-edge research in aging and health improvement through multiple initiatives.